Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pyush Moudgil

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Cardiology in Review|March 31, 2026
Poly(ADP-Ribose) Polymerases Inhibition in Cardiovascular Oncology: Protective Mechanisms Versus Clinical CardiotoxicityJatin Thukral, Pyush Moudgil, Hargun Kaur Ratol, et al.
Cardiology in Review|May 26, 2026
Pre-emptive and Prophylactic Strategies to Prevent Cardiovascular and Neurotoxicity in Chimeric Antigen Receptor T-Cell Therapy: The Role of Tocilizumab, Anakinra, and Cytokine-Targeted InterventionsJatin Thukral, Ninaad Sindhwani, Kuldeep Khan, et al.
Cardiology in Review|May 6, 2026
Global Longitudinal Strain as a Surveillance Tool in Hematologic Cancer-Related CardiotoxicityJatin Thukral, Pyush Moudgil, Ninaad Sindhwani, et al.
Cardiology in Review|February 19, 2026
Circulating Tumor DNA and Blood-Based Biomarkers for Predicting Cardiotoxicity in Cancer Therapy: Toward Precision Cardio-OncologyJatin Thukral, Pyush Moudgil, Navish Moudgil, et al.
Cardiology in Review|March 16, 2026
Second-Generation and Off-the-Shelf CAR Platforms: Emerging Cardiovascular Implications of Next-Generation Cellular ImmunotherapiesJatin Thukral, Pyush Moudgil, Abhay Mann, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Cardiology in Review|March 31, 2026
Poly(ADP-Ribose) Polymerases Inhibition in Cardiovascular Oncology: Protective Mechanisms Versus Clinical CardiotoxicityJatin Thukral, Pyush Moudgil, Hargun Kaur Ratol, et al.
Cardiology in Review|May 26, 2026
Pre-emptive and Prophylactic Strategies to Prevent Cardiovascular and Neurotoxicity in Chimeric Antigen Receptor T-Cell Therapy: The Role of Tocilizumab, Anakinra, and Cytokine-Targeted InterventionsJatin Thukral, Ninaad Sindhwani, Kuldeep Khan, et al.
Cardiology in Review|May 6, 2026
Global Longitudinal Strain as a Surveillance Tool in Hematologic Cancer-Related CardiotoxicityJatin Thukral, Pyush Moudgil, Ninaad Sindhwani, et al.
Cardiology in Review|February 19, 2026
Circulating Tumor DNA and Blood-Based Biomarkers for Predicting Cardiotoxicity in Cancer Therapy: Toward Precision Cardio-OncologyJatin Thukral, Pyush Moudgil, Navish Moudgil, et al.
Cardiology in Review|March 16, 2026
Second-Generation and Off-the-Shelf CAR Platforms: Emerging Cardiovascular Implications of Next-Generation Cellular ImmunotherapiesJatin Thukral, Pyush Moudgil, Abhay Mann, et al.
Pageof 2